Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.

Journal: Cell

Published: 2020-08-20

DOI: 10.1016/j.cell.2020.07.009

Affiliations: 57

Authors: 117

Go to article
Institutions Share
Department of Pediatrics, MSKCC, United States of America (USA) 0.20
CCBF Laboratory, United States of America (USA) 0.13
Weill Cornell Medicine (WCM), Cornell University, United States of America (USA) 0.13
Department of Surgery, MSKCC, United States of America (USA) 0.09
Fred and Pamela Buffett Cancer Center, UNMC, United States of America (USA) 0.04
Department of Medicine, MSKCC, United States of America (USA) 0.03
Proteomics Resource Center, The Rockefeller University, United States of America (USA) 0.03
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA) 0.02
School of Life Science and Technology, Tokyo Tech, Japan 0.02
Department of Biological Regulation, WIS, Israel 0.02
Department of Molecular Biology (MolBio), Princeton University, United States of America (USA) 0.02
Department of Pediatrics, Cornell University, United States of America (USA) 0.02
USC Keck School of Medicine, United States of America (USA) 0.02
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA) 0.01
Joan and Sanford I. Weill Department of Medicine, Cornell University, United States of America (USA) 0.01
Molecular Oncology Programme, CNIO, Spain 0.01
Department of Pathology and Laboratory Medicine, Cornell University, United States of America (USA) 0.01
Division of Gastroenterology and Hepatology, Cornell University, United States of America (USA) 0.01
Department of Pathology, UC San Diego, United States of America (USA) 0.01
Perelman School of Medicine, Penn, United States of America (USA) 0.01
Department of Pathology and Laboratory Medicine, UVM, United States of America (USA) 0.01
Public Health Sciences Division (PHS), FHCRC, United States of America (USA) 0.01
Department of Population Sciences, City of Hope, United States of America (USA) 0.01
Champalimaud Clinical Centre (CCC), Portugal 0.01
Lawrence Berkeley National Laboratory (LBNL), United States of America (USA) 0.01
Champalimaud Foundation, Portugal 0.01
Department of Biochemistry and Biophysics, Penn, United States of America (USA) 0.01
Gale and Ira Drukier Institute for Children’s Health, Cornell University, United States of America (USA) 0.01
Department of Biomolecular Sciences, WIS, Israel 0.01
Stanford Lucile Packard Children's Hospital (LPCH), United States of America (USA) 0.01
OSU Department of Veterinary Biosciences, United States of America (USA) 0.01
Department of Molecular Cell Biology, WIS, Israel 0.01
Department of Plant and Environmental Sciences, WIS, Israel 0.01
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.01
Department of Pathology, MSKCC, United States of America (USA) 0.01
Department of Immunology, Genetics and Pathology (IGP), UU, Sweden 0.01
Graduate Program in Areas of Basic and Applied Biology (BBA), UP, Portugal 0.01
Graduate School of Pharmaceutical Sciences, UTokyo, Japan 0
NYU Department of Microbiology, United States of America (USA) 0
Asturias Central University Hospital (HUCA), Spain 0
Institute for Research and Innovation in Health (I3S Consortium), Portugal 0
IRCCS Bambino Gesù Children's Hospital, Italy 0
EPFL Swiss Institute for Experimental Cancer Research (ISREC), Switzerland 0
Tri-Institutional PhD Program in Computational Biology and Medicine (CBM), United States of America (USA) 0
NIH National Cancer Institute (NCI), United States of America (USA) 0
Faculty of Medicine and Health Sciences (FMHS), LiU, Sweden 0
College of Medicine (YUCM), Yonsei University, South Korea 0
Yonsei Cancer Center, Yonsei University, South Korea 0
Department of Obstetrics and Gynecology, UTokyo, Japan 0
Precursory Research for Embryonic Science and Technology (PRESTO), JST, Japan 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER